IRIS
AQUARO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.755
AS - Asia 1.317
EU - Europa 920
SA - Sud America 296
AF - Africa 39
OC - Oceania 5
Totale 7.332
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.703
SG - Singapore 586
RU - Federazione Russa 555
HK - Hong Kong 269
BR - Brasile 251
CN - Cina 188
VN - Vietnam 159
FR - Francia 106
IT - Italia 71
DE - Germania 46
NL - Olanda 36
IN - India 34
CA - Canada 29
GB - Regno Unito 26
FI - Finlandia 24
AR - Argentina 19
BD - Bangladesh 18
MX - Messico 14
PL - Polonia 10
ES - Italia 8
IQ - Iraq 8
JP - Giappone 8
ZA - Sudafrica 8
LT - Lituania 7
UA - Ucraina 7
EC - Ecuador 6
TR - Turchia 6
ID - Indonesia 5
KE - Kenya 5
SE - Svezia 5
UZ - Uzbekistan 5
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
MA - Marocco 4
PH - Filippine 4
SA - Arabia Saudita 4
TZ - Tanzania 4
UY - Uruguay 4
AZ - Azerbaigian 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
KR - Corea 2
NI - Nicaragua 2
PE - Perù 2
TN - Tunisia 2
VE - Venezuela 2
AD - Andorra 1
AM - Armenia 1
DK - Danimarca 1
GH - Ghana 1
GM - Gambi 1
GN - Guinea 1
GY - Guiana 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
NC - Nuova Caledonia 1
NP - Nepal 1
PA - Panama 1
PF - Polinesia Francese 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
WS - Samoa 1
Totale 7.332
Salva come PNG Salva come JPEG
Città #
Dallas 3.006
San Jose 542
Council Bluffs 297
Hong Kong 268
Singapore 259
Ashburn 221
The Dalles 143
Santa Clara 137
Moscow 95
Lauterbourg 91
Hefei 83
Ho Chi Minh City 58
New York 40
Hanoi 34
Amsterdam 32
São Paulo 26
Beijing 25
Los Angeles 24
Orem 22
Da Nang 20
Chennai 19
Lappeenranta 17
Assago 16
Frankfurt am Main 14
Montreal 14
Munich 12
Denver 11
Brooklyn 10
London 10
Milan 10
Atlanta 9
Warsaw 9
Chicago 8
Seattle 8
Tokyo 8
Boston 7
Falkenstein 7
Mexico City 7
Phoenix 7
Rome 7
San Francisco 7
Toronto 7
Belo Horizonte 6
Curitiba 6
Haiphong 6
Ankara 5
Brasília 5
Charlotte 5
Düsseldorf 5
Helsinki 5
Johannesburg 5
New Delhi 5
Paris 5
Stockholm 5
Tashkent 5
Bologna 4
Campinas 4
Dar es Salaam 4
Honolulu 4
Montevideo 4
Mumbai 4
Nuremberg 4
Rio de Janeiro 4
Baghdad 3
Baku 3
Bishkek 3
Bragança Paulista 3
Buenos Aires 3
Casablanca 3
Fortaleza 3
Goiânia 3
Guarulhos 3
Guayaquil 3
Houston 3
Kingston 3
Manchester 3
Mar del Plata 3
Memphis 3
Nairobi 3
Ottawa 3
Portsmouth 3
Ribeirão Preto 3
Santiago 3
Votuporanga 3
Anápolis 2
Aracaju 2
Belém 2
Betim 2
Birmingham 2
Bismarck 2
Biên Hòa 2
Bogotá 2
Bom Despacho 2
Buon Ma Thuot 2
Bắc Ninh 2
Cairo 2
Calgary 2
Carapicuíba 2
Cleveland 2
Dhaka 2
Totale 5.842
Salva come PNG Salva come JPEG
Nome #
1,2,3-triazole-TSAO analogues: Synthesis and anti-HIV activity 2.770
N-Heterocyclic Carbene (NHC) Silver Complexes as Versatile Chemotherapeutic Agents Targeting Human Topoisomerases and Actin 82
Synthesis of novel N-Heterocyclic carbene-Ruthenium (II) complexes, “precious” tools with antibacterial, anticancer and antioxidant properties 80
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 79
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies 78
Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs 77
Modulation of energetic and lipid pathways by curcumin as a potential chemopreventive strategy in human prostate cancer cells 75
Enhancing the Anticancer and Anti-Inflammatory Properties of Curcumin in Combination with Quercetin, for the Prevention and Treatment of Prostate Cancer 70
ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION 70
Triclosan: A Small Molecule with Controversial Roles 70
Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity 69
The Ongoing Impact of COVID-19 on Pediatric Obesity 69
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 68
HIV-1 Structural Proteins or Cell-Signaling Factors? That Is the Question! 66
Are Nutraceuticals Effective in COVID‐19 and Post‐COVID Prevention and Treatment? 63
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies 62
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic 62
Drugs for COVID-19: An Update 61
Potential PDE4B inhibitors as promising candidates against SARS-CoV-2 infection 59
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 55
Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees 55
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 55
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 55
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 53
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 53
N-Heterocyclic Carbene-Gold(I) Complexes Targeting Actin Polymerization 51
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 50
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 47
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation 44
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine [(R)-PMPA] and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against Human Immunodeficiency Virus in Different Human Cell Systems 44
Antiviral Profile of HIV Inhibitors in Macrophages: Implications for Therapy 43
Attivita’ di farmaci inibitori del virus dell’immunodeficienza umana in macrofagi umani e correlazione con l’efficacia clinica 43
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus 43
Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression 43
Il macrofago e l’infezione da HIV. Ruolo delle cellule lungo sopravviventi nella patogenesi e nella terapia 43
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 42
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype- infection 42
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs 42
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 41
Cyclosaligenil-2’,3’-didehydro-2’,3’ – dideoxythymidine Monophosphate: efficient Intracellular Delivery of d4TMP 41
Viral Dynamic and mutations in the Pol Gene during primary HIV-1 infection 40
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity 39
Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage 39
Red-blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency, metabolism, and activity against human immunodeficiency virus or herpes simplex virus 39
HIV-1 B-subtype capsid protein: a characterization of amino acid's conservation and its significant association with integrase signatures 39
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist 38
Macrophages: a crucial reservoir for human immunodeficiency virus in the body 38
Presence of 2’,5’-Bis-O-(tert-butyldimethilsylil)-3’-spiro-5”-(4”-amino-1”,2”-oxathiole-2”,2”-dioxide)(TSAO)-resistant virus strain in TSAO-inexperienced HIV patients 38
Influenza virus A (H5N1): a pandemic risk? 37
Carbazole Derivatives as Antiviral Agents: An Overview 37
Inhibition of replication of human immunodeficiency virus in primary monocyte-derived macrophages by different antiviral drugs, and comparative efficacy in lymphocytes 37
Activity of masked 2’-3’-Dideoxynucleoside Monophosphate Derivatives Against Human Immunodeficiency Virus in Resting Macrophages 36
Therapeutic strategies towards HIV-1 infection in macrophages 36
Understanding HIV compartments and reservoirs 36
Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages 36
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 36
Nerve growth factor is an autocrine factor essential for the survival of macrophages infected by human immunodeficiency virus 36
Identification of Pinosylvin in Pinus nigra subsp. laricio: A Naturally Occurring Stilbenoid Suppressing LPS-Induced Expression of Pro-Inflammatory Cytokines and Mediators and Inhibiting the JAK/STAT Signaling Pathway 36
Inhibition of Dual/Mixed Tropic HIV-1 Isolates by CCR5-Inhibitors in Primary Lymphocytes and Macrophages 35
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir 35
Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus 35
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 35
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 35
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies 35
Anti-nerve growth factor Ab abrogates macrophage mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 35
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 35
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype 34
Improved antiviral activity of the aryloxymethoxyphosphoramidate (APA) prodrug of abacavir (ABC) is due to the formation of markeldy increased carbovir 5’-triphosphate metabolite levels 34
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 33
Intracellular metabolism of cyclosaligenyl 3’-azido-2’-3’-dideoxythymidine monophosphate, a prodrug of 3’-azido-2’-3’-dideoxythymidine (zidovudine) 33
Clinical implications of HIV dynamics and drug resistance in macrophages 33
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: new evidence and future perspectives 33
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs 33
Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus 33
Microbiological Characteristics and Physico-chemical Parameters of Fermented Milk Product Ergo-A Traditional Yogurt Product of Ethiopia 33
Identification of the novel KI Polyomavirus in paranasal and lung tissues 32
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages 32
HIV-1-associated dementia during HAART therapy 32
oxidative stress and HIV infection:target pathways for novel therapies? 32
Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives 32
Antiretrovirus activity of novel class of acyclic pyrimidine nucleoside phosphonates 32
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 31
Human immunodeficiency virus infection and acquired immunodeficiency sindrome dementia complex: Role of cells of monocyte-macrophage lineage 31
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 31
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 31
The Role of HIV Infection in Neurologic Injury 31
In vitro activity of inhibitors of late stages of the replication of HIV in chronically-infected macrophages 30
Highly Favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 (HIV-1) replication 30
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 30
Mannose-specific plant lectins from the amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection 30
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibitor of STAT1 expression 30
Glutathione inhibits HIV replication by acting at late stages of virus lifecycle 29
Peroxynitrite decomposition catalyst prevents apoptotic cell death in ha human astrocytoma cell line incubated with supernatants of HIV-infected macrophages 29
NEUROAIDS: VIROLOGICAL ASPECTS OF HIV INFECTION 29
Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line 29
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 29
Intracellular GSH content and HIV replication in human macrophages 28
The Potent Inhibition of Human Immunodeficiency Virus and Herpes Simplex Virus Type 1 by 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) in Primary Macrophages Is Determined by Drug Metabolism, Nucleotide Pools and Cytokines 27
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 27
Gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure 27
Totale 7.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.428 0 0 0 0 145 167 288 79 411 77 105 156
2025/20266.031 109 920 2.283 471 164 257 636 142 330 357 352 10
Totale 7.459